Marina Holz
@marinaholz.bsky.social
As the Executive Editor of BBA Reviews on Cancer, I am pleased to announce Call for Nominations: *BBA Rising Stars in Biochemistry & Biophysics 2026*!Nominate outstanding scientists within 10 years of their PhD for this prestigious award. Deadline: Dec 1, 2025.
lnkd.in/dRzrNbJZ
lnkd.in/dRzrNbJZ
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
November 3, 2025 at 3:26 PM
As the Executive Editor of BBA Reviews on Cancer, I am pleased to announce Call for Nominations: *BBA Rising Stars in Biochemistry & Biophysics 2026*!Nominate outstanding scientists within 10 years of their PhD for this prestigious award. Deadline: Dec 1, 2025.
lnkd.in/dRzrNbJZ
lnkd.in/dRzrNbJZ
Reposted by Marina Holz
Thank you to everyone who joined our recent committee meeting! #ASBMBJournals #JbiolChem
📸 Committee members here on #Bluesky: @chifungleephd.bsky.social, @marinaholz.bsky.social & @drohsopretty.bsky.social.
📸 Committee members here on #Bluesky: @chifungleephd.bsky.social, @marinaholz.bsky.social & @drohsopretty.bsky.social.
Today's #TBT post celebrates 120 years of the Journal of Biological Chemistry! The first issue of JBC was published in Oct. 1905. Here's the ASBMB Membership Committee w/a copy of that first issue! It was a fun moment looking back as the membership committee looks to the future.
asbmb.org/membership
asbmb.org/membership
October 9, 2025 at 8:16 PM
Thank you to everyone who joined our recent committee meeting! #ASBMBJournals #JbiolChem
📸 Committee members here on #Bluesky: @chifungleephd.bsky.social, @marinaholz.bsky.social & @drohsopretty.bsky.social.
📸 Committee members here on #Bluesky: @chifungleephd.bsky.social, @marinaholz.bsky.social & @drohsopretty.bsky.social.
This is what I was taking a pic of. Pretty epic.
October 9, 2025 at 9:59 PM
This is what I was taking a pic of. Pretty epic.
Reposted by Marina Holz
LAM–CAM: In Vivo Model for Rapid Analysis of Lymphangioleiomyomatosis Tumor Formation & Inhibition
Supports tumor formation & treatment, offers platform for drug screening & applications for medicine using PDXs
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/y5xnrkzx
Supports tumor formation & treatment, offers platform for drug screening & applications for medicine using PDXs
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/y5xnrkzx
September 16, 2025 at 4:29 PM
LAM–CAM: In Vivo Model for Rapid Analysis of Lymphangioleiomyomatosis Tumor Formation & Inhibition
Supports tumor formation & treatment, offers platform for drug screening & applications for medicine using PDXs
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/y5xnrkzx
Supports tumor formation & treatment, offers platform for drug screening & applications for medicine using PDXs
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/y5xnrkzx
Check out the latest paper from our lab!
LAM–CAM: In Vivo Model for Rapid Analysis of Lymphangioleiomyomatosis Tumor Formation & Inhibition
Supports tumor formation & treatment, offers platform for drug screening & applications for medicine using PDXs
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/y5xnrkzx
Supports tumor formation & treatment, offers platform for drug screening & applications for medicine using PDXs
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/y5xnrkzx
September 16, 2025 at 11:54 PM
Check out the latest paper from our lab!
Reposted by Marina Holz
The latest issue of the #AJRCMB is now live! Take a look: www.atsjournals.org/toc/ajrcmb/c...
@atscommunity.bsky.social #medsky
@atscommunity.bsky.social #medsky
August 29, 2025 at 3:23 PM
The latest issue of the #AJRCMB is now live! Take a look: www.atsjournals.org/toc/ajrcmb/c...
@atscommunity.bsky.social #medsky
@atscommunity.bsky.social #medsky
Reposted by Marina Holz
Congratulations to Bryan Jimenez for graduating with his master's degree from NYMC. He spent some time with us last year, and he was brilliant in my Cell Bio exam this year! Wishing Bryan the best for his future. He is on the job market to complete some more science before starting medical school.
June 2, 2025 at 10:21 PM
Congratulations to Bryan Jimenez for graduating with his master's degree from NYMC. He spent some time with us last year, and he was brilliant in my Cell Bio exam this year! Wishing Bryan the best for his future. He is on the job market to complete some more science before starting medical school.
Our paper “Lymphangioleiomyomatosis (LAM) Patient Research Priorities (LAM-PREP” is now online @accpchest.bsky.social #pulmonary www.chestpulmonary.org/article/S294...
Lymphangioleiomyomatosis (LAM) Patient Research Priorities (LAM-PREP): Developing a Patient-Centered Research Agenda.
Engaging patients in developing research agendas is recognized as critical in advancing
scientific discovery and improving clinical care. There is a scarcity of such studies
for respiratory diseases, ...
www.chestpulmonary.org
May 24, 2025 at 11:03 PM
Our paper “Lymphangioleiomyomatosis (LAM) Patient Research Priorities (LAM-PREP” is now online @accpchest.bsky.social #pulmonary www.chestpulmonary.org/article/S294...
Thank you Inside Higher Ed for highlighting our work!
May 21, 2025 at 5:47 PM
Thank you Inside Higher Ed for highlighting our work!
Reposted by Marina Holz
I am so excited about this study! Our research team analyzed anxiety in 2,106 professors across 62 US institutions - the largest study on faculty anxiety to date! Thank you to all who participated!
Familial and Parental Relationships Can Ease Anxiety Among Academics in the United States https://www.medrxiv.org/content/10.1101/2025.04.30.25326730v1
May 3, 2025 at 6:19 PM
I am so excited about this study! Our research team analyzed anxiety in 2,106 professors across 62 US institutions - the largest study on faculty anxiety to date! Thank you to all who participated!
Reposted by Marina Holz
Familial and Parental Relationships Can Ease Anxiety Among Academics in the United States https://www.medrxiv.org/content/10.1101/2025.04.30.25326730v1
May 1, 2025 at 5:11 PM
Familial and Parental Relationships Can Ease Anxiety Among Academics in the United States https://www.medrxiv.org/content/10.1101/2025.04.30.25326730v1